The Latest in Multiple Sclerosis

Clinical Neurology News

ATTAIN: Peginterferon beta-1a remains efficacious for MS in long term

April 29, 2016

Multiple Sclerosis

Clinical Neurology News

Fewer new lesions, side effects differentiate fingolimod from dimethyl fumarate

April 28, 2016

Multiple Sclerosis

Neurology Reviews

Clemastine Fumarate May Repair Myelin in People With MS

April 25, 2016

Multiple Sclerosis

Clinical Neurology News

Small study: OTC antihistamine shows potential as a remyelinating agent in MS

April 20, 2016

Multiple Sclerosis

Clinical Neurology News

New data help guide the stopping of disease-modifying drugs in MS

April 19, 2016

Multiple Sclerosis

Clinical Neurology News

AAN updates botulinum toxin guidelines for most established uses

April 19, 2016

Clinical Neurology News

Patients suffer morbidity due to MS misdiagnosis

April 17, 2016

Multiple Sclerosis

Clinical Neurology News

Rosacea linked to several autoimmune diseases in women

April 13, 2016

Multiple Sclerosis

Clinical Neurology News

Rituximab bests fingolimod in MS patients switching from natalizumab

April 4, 2016

Multiple Sclerosis

Clinical Neurology News

FDA: CT scans safe for patients with electronic medical devices

April 1, 2016

Neurology Reviews

ORATORIO Subgroup Analysis Looks at Baseline Enhancement Activity’s Effect on Outcome

March 23, 2016

Multiple Sclerosis

Neurology Reviews

High Coffee Consumption May Decrease Risk for MS

March 22, 2016

Multiple Sclerosis

Neurology Reviews

Drugs for Progressive MS Could Target Multiple Disease Mechanisms

March 22, 2016

Multiple Sclerosis

Clinical Neurology News

Evidence builds for mesenchymal stem cell therapy in MS

March 7, 2016

Multiple Sclerosis

Clinical Neurology News

High coffee consumption linked to decreased risk for MS

March 3, 2016

Multiple Sclerosis